The Crucible of CRISPR: Evaluating the Future of In-Vivo Gene Editing After a Fatal Clinical Setback
The field of genomic medicine, long heralded as the final frontier of curative science, has reached a somber and definitive crossroads. The recent death of a participant in a late-stage…
